Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: |
Title | Immuno-Oncology Biotech | |
Description | About A biotechnology company specializing in |
Keywords | N/A |
WebSite | ioncologi.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$449,346
Last updated: 2023-05-08 23:46:04
ioncologi.com has Semrush global rank of 23,554,923. ioncologi.com has an estimated worth of US$ 449,346, based on its estimated Ads revenue. ioncologi.com receives approximately 51,848 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, ioncologi.com is safe to visit. |
Purchase/Sale Value | US$449,346 |
Daily Ads Revenue | US$415 |
Monthly Ads Revenue | US$12,444 |
Yearly Ads Revenue | US$149,322 |
Daily Unique Visitors | 3,457 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ioncologi.com. | A | 600 | IP: 198.71.232.3 |
ioncologi.com. | NS | 3600 | NS Record: ns48.domaincontrol.com. |
ioncologi.com. | NS | 3600 | NS Record: ns47.domaincontrol.com. |
ioncologi.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
ioncologi.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
ioncologi.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all |
ioncologi.com. | TXT | 3600 | TXT Record: NETORGFT2998056.onmicrosoft.com |
(352) 559-5100 (352) 559-5100 About Us iOncologi, Inc. iOncologi, Inc. (iOi) is a biotechnology company specializing in immuno-oncology. Launched as a ’spin-out’ cancer immunotherapy firm from the University of Florida, iOi’s founders have developed a novel stem cell therapy that overcomes resistance to immune checkpoint inhibitors in multiple cancers. Novel Immunotherapy Platform Immune checkpoint inhibitors (ICIs), such as anti-CTLA-4 and anti-PD-1 monoclonal antibodies, block inhibitory pathways that prevent the immune system from attacking cancer. These drugs essentially take the brakes off of the body’s own defenses against cancer growth and have dramatically altered the landscape for the treatment of refractory tumors. With several new FDA-approved indications and global market sales projected to exceed $30 billion (USD) in revenue by 2026, ICIs have offered new hope for curative treatment of many advanced malignancies. However, currently over two-thirds of patients treated with |
HTTP/1.1 301 Moved Permanently location: https://ioncologi.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Sat, 30 Oct 2021 21:58:33 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Sat, 30 Oct 2021 21:58:33 GMT |
Domain Name: IONCOLOGI.COM Registry Domain ID: 2093846731_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-29T17:58:07Z Creation Date: 2017-01-29T01:53:40Z Registry Expiry Date: 2023-01-29T01:53:40Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS47.DOMAINCONTROL.COM Name Server: NS48.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T08:13:25Z <<< |